We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$27.3B
AUM Growth
-$1.47B
Cap. Flow
+$9.9M
Cap. Flow %
0.04%
Top 10 Hldgs %
22.1%
Holding
2,294
New
116
Increased
639
Reduced
784
Closed
160

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 14.74%
3 Healthcare 12.18%
4 Consumer Discretionary 10.36%
5 Real Estate 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKOH icon
1976
Park-Ohio Holdings
PKOH
$554M
$39K ﹤0.01%
2,800
+800
+40% +$14.4K
UDMY
1977
DELISTED
Udemy
UDMY
$39K ﹤0.01%
3,200
VIRX
1978
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$39K ﹤0.01%
8,400
FLNT
1979
Fluent
FLNT
$102M
$38K ﹤0.01%
3,100
INVA icon
1980
Innoviva
INVA
$1.58B
$38K ﹤0.01%
+2,000
New +$35.7K
RUN icon
1981
Sunrun
RUN
$2.37B
$38K ﹤0.01%
1,255
DKNG icon
1982
DraftKings
DKNG
$11.4B
$37K ﹤0.01%
1,947
TNYA icon
1983
Tenaya Therapeutics
TNYA
$168M
$37K ﹤0.01%
3,200
VERA icon
1984
Vera Therapeutics
VERA
$2.54B
$37K ﹤0.01%
1,600
KNTE
1985
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$37K ﹤0.01%
3,300
CELC icon
1986
Celcuity
CELC
$4.03B
$35K ﹤0.01%
3,800
CHWY icon
1987
Chewy
CHWY
$8.54B
$35K ﹤0.01%
864
-40,000
-98% -$1.82M
GTN icon
1988
Gray Television
GTN
$407M
$35K ﹤0.01%
1,600
-1,200
-43% -$26.5K
TARS icon
1989
Tarsus Pharmaceuticals
TARS
$2.56B
$35K ﹤0.01%
2,100
LENZ
1990
LENZ Therapeutics
LENZ
$172M
$35K ﹤0.01%
1,000
+471
+89% +$29.5K
NAGE
1991
Niagen Bioscience
NAGE
$256M
$35K ﹤0.01%
14,600
NVTA
1992
DELISTED
Invitae Corporation
NVTA
$35K ﹤0.01%
4,500
XXII
1993
22nd Century Group
XXII
$1.47M
0
CTEV
1994
Claritev Corp
CTEV
$368M
$34K ﹤0.01%
+183
New +$30.1K
FSBC icon
1995
Five Star Bancorp
FSBC
$1B
$33K ﹤0.01%
1,200
IPSC icon
1996
Century Therapeutics
IPSC
$381M
$33K ﹤0.01%
2,700
STRA icon
1997
Strategic Education
STRA
$1.71B
$33K ﹤0.01%
500
ZG icon
1998
Zillow
ZG
$7.02B
$33K ﹤0.01%
699
BCRX icon
1999
BioCryst Pharmaceuticals
BCRX
$2.37B
$32K ﹤0.01%
+2,000
New +$32.1K
FWRG icon
2000
First Watch Restaurant Group
FWRG
$747M
$32K ﹤0.01%
2,500

Similar funds

STRS Ohio's Q1 2022 Portfolio in Review

As of Q1 2022, STRS Ohio held 2,294 positions worth $27.3B, down 5.1% from $28.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

STRS Ohio's Q1 2022 filing shows 116 new, 639 increased, 784 reduced and 160 closed positions. Its largest new stake was Doximity: 435,000 shares worth $22.7M. The largest sale was iShares MSCI EAFE ETF, an estimated $120M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • STRS Ohio's largest Q1 2022 buy was Doximity: 435,000 shares worth $22.7M.
  • STRS Ohio added most to SVB Financial Group in Q1 2022, an estimated $62M increase.
  • STRS Ohio's biggest Q1 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $120M.
  • STRS Ohio fully exited iShares MSCI Emerging Markets ETF in Q1 2022, selling an estimated $104M.
  • STRS Ohio's ten largest holdings make up 22% of its $27.3B portfolio in Q1 2022.
  • STRS Ohio opened 116 new positions and closed 160 in Q1 2022.
  • STRS Ohio's portfolio value fell 5.1% quarter-over-quarter to $27.3B.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.